Trial Profile
Prospective, Multicenter, Non-interventional Study to Characterize Profile of Patient With Psoriatic Arthritis Depending on Whether Their Disease is Managed by a Dermatologist or by a Rheumatologist, and Starting Ustekinumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary)
- Indications Psoriatic arthritis
- Focus Therapeutic Use
- Acronyms PROUST
- Sponsors Janssen-Cilag
- 13 May 2020 Status changed from active, no longer recruiting to completed.
- 31 Oct 2019 Planned primary completion date changed from 30 Oct 2019 to 4 Apr 2020.
- 03 Oct 2019 Status changed from recruiting to active, no longer recruiting.